ORIGINAL RESEARCH
Published on 29 May 2025
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting
doi 10.3389/fonc.2025.1564888
- 426 views
28
Total downloads
857
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: